The problem arises when systems blur distinctions in ways that confuse patients and strain teams. The real fault line in ...

The U.S. government has signed health deals with at least nine African countries, part of its new approach to global health ...

In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...

Science Signaling retracted a 2017 paper that linked a specific amyloid form (amyloid-beta 56) to tau pathology after an ...

Beyond sicca symptoms, Sjögren's disease can involve non-glandular manifestations such as dysautonomia and small fiber neuropathy that are often difficult to assess and manage. At this year's American ...

Concurrently, low state immunization levels pose a significant and immediate risk, particularly for measles, which is ...

Starting an incretin receptor agonist -- especially tirzepatide (Mounjaro, Zepbound) -- was associated with reduced risks of ...

At the recent American Society of Hematology annual meeting, phase I data highlighted a next-generation, CD19-targeted, interleukin-18-secreting "armored" CAR T-cell therapy that is designed to ...

Early initiation of tofersen (Qalsody) was associated with a numerically slower decline in people with SOD1 amyotrophic ...

The FDA has expanded the indication of ferric maltol (Accrufer) capsules for the treatment of iron deficiency to include ...

At the San Antonio Breast Cancer Symposium, investigators reported findings from a retrospective study exploring whether ...

Medicaid programs made more than $200 million in improper payments to healthcare providers between 2021 and 2022 for people ...